Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
NDC 58118-8020, Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate, tablet, from Clinical Solutions Wholesale, LLC.
- Product NDC
- 58118-8020
- Status
- Listed
- Labeler
- Clinical Solutions Wholesale, LLC
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207000
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/58118-8020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58118-8020-8 | 58118802008 | 30 TABLET in 1 BLISTER PACK (58118-8020-8) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/273b79ac-2c62-4407-9cd1-2a2964ef13ba
Use it
Look up 58118-8020 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58118-8020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58118-8020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.